全文获取类型
收费全文 | 18439篇 |
免费 | 1453篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 662篇 |
妇产科学 | 532篇 |
基础医学 | 2508篇 |
口腔科学 | 232篇 |
临床医学 | 2694篇 |
内科学 | 3216篇 |
皮肤病学 | 198篇 |
神经病学 | 2019篇 |
特种医学 | 470篇 |
外科学 | 1491篇 |
综合类 | 260篇 |
一般理论 | 38篇 |
预防医学 | 2683篇 |
眼科学 | 361篇 |
药学 | 1026篇 |
中国医学 | 7篇 |
肿瘤学 | 1335篇 |
出版年
2023年 | 131篇 |
2022年 | 193篇 |
2021年 | 410篇 |
2020年 | 240篇 |
2019年 | 374篇 |
2018年 | 432篇 |
2017年 | 332篇 |
2016年 | 343篇 |
2015年 | 440篇 |
2014年 | 578篇 |
2013年 | 896篇 |
2012年 | 1215篇 |
2011年 | 1312篇 |
2010年 | 716篇 |
2009年 | 600篇 |
2008年 | 1145篇 |
2007年 | 1215篇 |
2006年 | 1251篇 |
2005年 | 1191篇 |
2004年 | 1067篇 |
2003年 | 1009篇 |
2002年 | 1022篇 |
2001年 | 173篇 |
2000年 | 164篇 |
1999年 | 175篇 |
1998年 | 224篇 |
1997年 | 168篇 |
1996年 | 154篇 |
1995年 | 129篇 |
1994年 | 144篇 |
1993年 | 137篇 |
1992年 | 115篇 |
1991年 | 82篇 |
1990年 | 107篇 |
1989年 | 108篇 |
1988年 | 100篇 |
1987年 | 85篇 |
1986年 | 100篇 |
1985年 | 92篇 |
1984年 | 100篇 |
1983年 | 81篇 |
1982年 | 109篇 |
1981年 | 86篇 |
1980年 | 100篇 |
1979年 | 66篇 |
1978年 | 78篇 |
1977年 | 69篇 |
1975年 | 65篇 |
1974年 | 58篇 |
1973年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Jean-Pierre Lindenmayer M.D. Ruth Bernstein-Hyman Ph.D. Sandra Grochowski B.A. 《The Psychiatric quarterly》1994,65(4):299-322
Schizophrenic psychopathology is heterogeneous and multidimensional. Various strategies have been developed over the past
several years to assess and measure more accurately discrete domains of psychopathology. One of the more fruitful strategies
to investigate more homogenous domains of psychopathology has been the positive-negative syndrome approach. However, this
approach is unable to address a number of important issues. Most schizophrenics present a mixed syndrome; the criteria for
what constitutes a positive and negative syndrome are variable; distinguishing primary from secondary negative symptoms can
be difficult. In order to address some of these problems, we propose the introduction of a five syndrome model based on a
reanalysis of factor analytic procedures used on 240 schizophrenics assessed with the Positive and Negative Syndrome Scale
(PANSS). We present data on a 5-factor solution which appears to best fit the psychopathological data and which is supported
by three independent and comparable factor analyses; negative, positive, excitement, cognitive and depression/anxiety domains
of psychopathology give patients their individual mark. Data on internal consistency of the five factors and on initial validation
using demographic and clinical variables are presented. 相似文献
72.
Ast Gil; Goldblatt Drora; Waisman Ari; Sperling Ruth; Mozes Edna; Sperling Joseph 《International immunology》1994,6(8):1097-1105
73.
John D. England Fabia Gamboni Michele A. Ferguson S. Rock Levinson 《Muscle & nerve》1994,17(6):593-598
The axolemmal distribution of voltage-gated sodium channels largely determines the regions of axonal electrical excitability. Using a wellcharacterized anti–sodium channel antibody, we examined peripheral nerve fibers focally injured by exposure to the neurotoxic agent, potassium tellurite (K2TeO3). Immunocytochemical and radioimmunoassay data showed a focal accumulation of sodium channels within the tips of injured axons. The major increase in sodium channel concentration occurred between 7 and 11 days after toxin exposure; however, immunocytochemically, excess sodium channels persisted in several axonal endings for a much longer time. The accumulation of sodium channels at injured axonal tips may be responsible, in part, for ectopic axonal excitability and the resulting abnormal sensory phenomena (especially pain and paresthesias) which frequently complicate peripheral nerve injury in humans. © 1994 John Wiley & Sons, Inc. 相似文献
74.
Jun Gu Yang O Huh Feng Jiang Nancy P Caraway Jorge E Romaguera Tanweer M Zaidi Ricardo L Fernandez Huazhong Zhang Issa F Khouri Ruth L Katz 《Modern pathology》2004,17(5):553-560
Mantle cell lymphoma is non-Hodgkin's B-cell lymphoma characterized by the t(11;14)(q13;q32) translocation. Peripheral blood involvement of mantle cell lymphoma is usually associated with a poor prognosis and therefore, its identification is clinically important. In this study, we performed cyclin D1/IgH-probe fusion fluorescence in situ hybridization analysis on 223 peripheral blood samples: 185 from 125 mantle cell lymphoma patients, and 38 normal controls. The cutoff values for the test were established using normal controls. Flow cytometry on peripheral blood and corresponding bone marrow samples was used to evaluate this test. In all, 26% of the 185 peripheral blood samples and 27% of the 161 corresponding bone marrow samples were flow cytometry positive for mantle cell lymphoma. The mean numbers of single and- double-fusion signals and the mean number of CD5/CD19-positive cells, absolute blood lymphocyte count, and white blood cell count were significantly higher in peripheral blood and corresponding bone marrow samples with mantle cell lymphoma-positive flow cytometry. Double-fusion signals were more specific than single-fusion ones. Fluorescence in situ hybridization was far more likely to be positive for mantle cell lymphoma when the peripheral blood and the corresponding bone marrow samples had positive flow cytometry results or morphology (P<0.01). Our study indicates that cyclin D1/IgH-fusion fluorescence in situ hybridization analysis could be used to determine the presence and character of circulating mantle cell lymphoma cells in peripheral blood, thus enhancing our ability to evaluate leukemic mantle cell lymphoma and minimum residual disease. 相似文献
75.
Lorraine N Clark Eneli Haamer Helen Mejia-Santana Juliette Harris Suzanne Lesage Alexandra Durr Sabine Janin Bs Katja Hedrich Elan D Louis Lucien J Cote Howard Andrews Stanley Fahn Cheryl Waters Blair Ford Steven Frucht William Scott Christine Klein Alexis Brice Hanno Roomere Ruth Ottman Karen Marder 《Movement disorders》2007,22(7):932-937
Parkin mutations account for the majority of familial and sporadic early onset Parkinson's disease (EOPD) cases with a known genetic association. More than 100 mutations have been described in the Parkin gene that includes homozygous, compound heterozygous, and single heterozygous mutations. We have designed a Parkin mutation genotyping array (gene chip) that includes published Parkin sequence variants and allows their simultaneous detection. The chip was validated by screening 85 PD cases and 47 controls previously tested for Parkin mutations. Similar genotyping microarrays have been developed for other genetically heterogeneous diseases including age-related macular degeneration. Here, we show the utility of a genotyping array for Parkinson's disease by analysis of 60 subjects from the Genetic Epidemiology of Parkinson Disease (GEPD) study that includes 15 early-onset PD case probands and 45 relatives. 相似文献
76.
77.
78.
79.
80.